Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Reiche

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
European Urology|July 8, 2020
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate CancerMarkus Kreuz, Dominik J Otto, Susanne Fuessel, et al.
Leukemia|January 6, 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.
Leukemia|February 17, 2026
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-celThomas C Wiemers, Nora Grieb, Maximilian Ferle, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Nature Cancer|April 19, 2024
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Cancer Cell|December 5, 2025
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myelomaMichael Rade, David Fandrei, Markus Kreuz, et al.
Cytotherapy|November 11, 2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeDelphine Ammar, Carmen Sanges, David Henderson, et al.
NPJ Digital Medicine|August 1, 2025
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapiesUlrike Weirauch, Markus Kreuz, Colin Birkenbihl, et al.
Nature Reviews. Urology|May 29, 2020
Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
European Urology|July 8, 2020
ProstaTrend-A Multivariable Prognostic RNA Expression Score for Aggressive Prostate CancerMarkus Kreuz, Dominik J Otto, Susanne Fuessel, et al.
Leukemia|January 6, 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.
Leukemia|February 17, 2026
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-celThomas C Wiemers, Nora Grieb, Maximilian Ferle, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?Sonia Guedan, Maik Luu, Delphine Ammar, et al.
Nature Cancer|April 19, 2024
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.
Journal for Immunotherapy of Cancer|May 16, 2022
Time to evolve: predicting engineered T cell-associated toxicity with next-generation modelsEmmanuel Donnadieu, Maik Luu, Miriam Alb, et al.
Cancer Cell|December 5, 2025
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myelomaMichael Rade, David Fandrei, Markus Kreuz, et al.
Cytotherapy|November 11, 2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in EuropeDelphine Ammar, Carmen Sanges, David Henderson, et al.
NPJ Digital Medicine|August 1, 2025
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapiesUlrike Weirauch, Markus Kreuz, Colin Birkenbihl, et al.
Nature Reviews. Urology|May 29, 2020
Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
Pageof 8